Aimee Foord
Pediatric Hematology-Oncology · Las Vegas, NVNPI 1821312844
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $27,659 of the $41,072 with a category attached, or 67.3%. 30 manufacturers reported payments, led by Sanofi at 41.6% of the total. 2025 is the largest year on record at $24,165, more than ten times the $621 reported in 2022.
Across 95 payments — averaging $432.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$17K
- Sobi, Inc$8K
- CSL Behring$6K
- HEMA Biologics, LLC$3K
- Pfizer$3K
- Novo Nordisk$2K
- plus $2K from 24 others
Across 22 payments — averaging $804.23 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sanofi US Services Inc.$14K
- Agios Pharmaceuticals, Inc.$4K
What the payments were for
- Consulting fees$27,65967%
- Speaking & faculty fees$5,20013%
- Travel & lodging$4,34211%
- Food & beverage$3,8719%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 14 | $17,073 |
| Sobi, Inc | 7 | $7,911 |
| CSL Behring | 15 | $5,925 |
| HEMA Biologics, LLC | 1 | $3,025 |
| Pfizer | 7 | $2,673 |
| Novo Nordisk | 6 | $2,180 |
| Octapharma USA, Inc. | 4 | $356 |
| Bayer | 4 | $277 |
| Pharming Healthcare, Inc. | 3 | $269 |
| Kedrion Biopharma, Inc. | 4 | $215 |
| Bio Products Laboratory USA, Inc. | 3 | $141 |
| Emmaus Medical, Inc. | 1 | $137 |
| Spark Therapeutics, Inc. | 1 | $125 |
| Janssen Scientific Affairs, LLC | 1 | $115 |
| Genentech USA, Inc. | 4 | $102 |
| Chiesi USA, Inc. | 2 | $72 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $60 |
| Adaptive Biotechnologies Corporation | 2 | $55 |
| Incyte Corporation | 2 | $41 |
| Jazz Pharmaceuticals Inc. | 1 | $39 |
| Genetix Biotherapeutics Inc | 2 | $37 |
| Pharmacosmos Therapeutics Inc. | 1 | $35 |
| USWM, LLC | 1 | $31 |
| Syndax Pharmaceuticals, Inc. | 1 | $29 |
| Biogen | 1 | $28 |
| Novartis | 1 | $28 |
| Biomarin Pharmaceutical Inc. | 1 | $25 |
| Servier Pharmaceuticals LLC | 1 | $25 |
| Apellis Pharmaceuticals, Inc. | 1 | $24 |
| RARE Disease Therapeutics, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few pediatric hematology-oncology providers in Nevadato place this figure against a meaningful peer group, so we don't.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CerezymeImiglucerase | 11 | $528,965 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| SanofiCerezyme | $17,073 | $528,96511 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few pediatric hematology-oncology providers in Nevadaon file to place this against a meaningful peer group, so we don't.
Other pediatric hematology-oncology in Las Vegas
- Daisy CortesLas Vegas$385K
- Jenny Gober McDanielLas Vegas$43K
- Nik Nik Abdul RashidLas Vegas$32K
- Joseph LaskyLas Vegas$16K
- Jerry ReevesLas Vegas$12K
- Waseem AlhushkiLas Vegas$3K
- Alan IkedaLas Vegas$1K
- Michael GrahamLas Vegas$1K
- Sumit GuptaLas Vegas$1K
- Raul Montiel-EsparzaLas Vegas$794
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.